Outcomes of using various designs of carotid stents
https://doi.org/10.29001/2073-8552-2021-36-1-30-37
Abstract
It is assumed that the characteristics of stents including design of device may be predictors of adverse outcomes in carotid stenting. New stent designs enter the market and the stent manufacturers declare their ability to prevent periprocedural and postprocedural embolisms. The article provides an overview of clinical trials comparing the incidence rates of restenosis and ischemic complications in carotid artery stenting with various stent designs. In theory, the closed-cell stents and doublelayer stents are superior to the open-cell stents in preventing the postprocedural cerebral embolisms. However, the clinical significance of this phenomenon has not been proven, and the data on the effect of various carotid stent types on the stenting results remain controversial. In many cases, the choice of stent depends on the anatomy of the target vessel. The results of new randomized controlled clinical trials may clarify the clinical relevance of various stent designs.
Keywords
brachiocephalic arteries,
carotid artery,
carotid stenting,
carotid devices,
carotid protection devices
Supporting agencies: This work was supported by the Russian Science Foundation (Grant No. 18-15-00080).
About the Authors
O. S. Osipova
Meshalkin National Medical Research Center
Russian Federation
Russian Federation
Postgraduate Student, Center for Vascular and Hybrid Surgery
15, Rechkunovskaya str., Novosibirsk, 630055, Russian Federation
I. V. Popova
Meshalkin National Medical Research Center
Russian Federation
Russian Federation
Cand. Sci. (Med.), Research Scientist, Center for Vascular and Hybrid Surgery
15, Rechkunovskaya str., Novosibirsk, 630055, Russian Federation
V. B. Starodubtsev
Meshalkin National Medical Research Center
Russian Federation
Russian Federation
Cand. Sci. (Med.), Leading Research Scientist, Center for Vascular and Hybrid Surgery
15, Rechkunovskaya str., Novosibirsk, 630055, Russian Federation
S. V. Bugurov
Meshalkin National Medical Research Center
Russian Federation
Russian Federation
Interventional Cardiologist, Junior Research Scientist, Department of Vascular Pathology and Hybrid Technologies, Center for Vascular and Hybrid Surgery
15, Rechkunovskaya str., Novosibirsk, 630055, Russian Federation
A. V. Cheban
Meshalkin National Medical Research Center
Russian Federation
Russian Federation
Cardiovascular Surgeon, Junior Research Scientist, Department of Vascular Pathology and Hybrid Technologies, Center for Vascular and Hybrid Surgery
15, Rechkunovskaya str., Novosibirsk, 630055, Russian Federation
A. A. Karpenko
Meshalkin National Medical Research Center
Russian Federation
Russian Federation
Dr. Sci. (Med.), Professor, Head of the Center for Vascular and Hybrid Surgery
15, Rechkunovskaya str., Novosibirsk, 630055, Russian Federation
References
1. Kolominsky-Rabas P.L., Weber M., Gefeller O., Neundoerfer B., Heuschmann P.U. Epidemiology of ischemic stroke subtypes according to TOAST criteria: Incidence, recurrence, and long-term survival in ischemic stroke subtypes: A population-based study. Stroke. 2001;32(12):2735–2740. DOI: 10.1161/hs1201.100209.
2. Roubin G.S., New G., Iyer S.S., Vitek J.J., Al-Mubarak N., Liu M.W. et al. Immediate and late clinical outcomes of carotid artery stenting in patients with symptomatic and asymptomatic carotid artery stenosis: a 5-year prospective analysis. Circulation. 2001;103(4):532–537. DOI: 10.1161/01.cir.103.4.532.
3. Aboyans V., Ricco J.B., Bartelink M.L.E.L., Björck M., Brodmann M., Cohnert T. et al. Editor’s Choice – 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur. J. Vasc. Endovasc. Surg. 2018;55(3):305–368. DOI: 10.1016/j.ejvs.2017.07.018.
4. AbuRahma A.F., Mousa A.Y. Current Status of Carotid Stenting Versus Endarterectomy. Adv. Surg. 2016;50(1):235–256. DOI: 10.1016/j.yasu.2016.04.004.
5. Batchelder A.J., Saratzis A., Naylor A.R. Ross Naylor A. Editor’s Choice – Overview of Primary and Secondary Analyses From 20 Randomised Controlled Trials Comparing Carotid Artery Stenting With Carotid Endarterectomy. Eur. J. Vasc. Endovasc. Surg. 2019;58(4):479–493. DOI: 10.1016/j.ejvs.2019.06.003.
6. Brown K.A., Itum D.S., Duwayri Y., Reeves J.G., Rajani R., Veeraswamy R.K. et al. Influence of the hostile neck on restenosis after carotid stenting. Ann. Vasc. Surg. 2015;29(1):9–14. DOI: 10.1016/j.avsg.2014.06.002.
7. Wholey M.H., Al-Mubarek N., Wholey M.H. Updated review of the global carotid artery stent registry. Cathete. Cardiovasc. Interv. 2003;60(2):259–266. DOI: 10.1002/ccd.10645.
8. Eckstein H.H., Ringleb P., Allenberg J.R., Berger J., Fraedrich G., Hacke W. et al. Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: А multinational, prospective, randomised trial. Lancet Neurol. 2008;7(10):893–902. DOI: 10.1016/S1474-4422(08)70196-0.
9. Bonati L.H., Fraedrich G., Carotid Stenting Trialists’ Collaboration. Age modifies the relative risk of stenting versus endarterectomy for symptomatic carotid stenosis – A pooled analysis of EVA-3S, SPACE and ICSS. Eur. J. Vasc. Endovasc. Surg. 2011;41(2):153–158. DOI: 10.1016/j.ejvs.2011.01.001.
10. Müller-Hülsbeck S., Schäfer P.J., Charalambous N., Schaffner S.R., Heller M., Jahnke T. Comparison of carotid stents: an in-vitro experiment focusing on stent design. J. Endovasc. Ther. 2009;16(2):168–177. DOI: 10.1583/08-2539.1.
11. Schofer J., Musiałek P., Bijuklic K., Kolvenbach R., Trystula M., Siudak Z. et al. A Prospective, Multicenter Study of a Novel Mesh-Covered Carotid Stent the CGuard CARENET Trial (Carotid Embolic Protection Using MicroNet). JACC Cardiovasc. Interv. 2015;8(9):1229–1234. DOI: 10.1016/j.jcin.2015.04.016.
12. Musialek P., Mazurek A., Trystula M., Borratynska A., Lesniak-Sobelga A., Urbanczyk M. et al. Novel PARADIGM in carotid revascularisation: Prospective evaluation of All-comer peRcutaneous cArotiD revascularisation in symptomatic and Increased-risk asymptomatic carotid artery stenosis using CGuardTM MicroNet-covered embolic prevention stent system. EuroIntervention. 2016;12(5):e658–670. DOI: 10.4244/EIJY16M05_02.
13. Mathur A., Dorros G., Iyer S.S., Vitek J.J., Yadav S.S., Roubin G.S. Palmaz stent compression in patients following carotid artery stenting. Cathet. Cardiovasc. Diagn. 1997;41(2):137–140. DOI: 10.1002/(sici)1097-0304(199706)41:2<137::aid-ccd7>3.0.co;2-8.
14. Da Paz O. G., Guillaumon A.T., Lopes T.M., Weiler M., Cendes F., Balthazar M.L.F. Carotid stenting versus endarterectomy cognitive outcomes. Ann. Vasc. Surg. 2014;28(4):893–900. DOI: 10.1016/j.avsg.2013.10.010.
15. Rosenfield K., Matsumura J.S., Chaturvedi S., Riles T., Ansel G.M., Metzger D.C. et al. Randomized trial of stent versus surgery for asymptomatic carotid stenosis. N. Engl. J. Med. 2016;374(1):1011–1020. DOI: 10.1056/NEJMoa1515706.
16. Bosiers M., de Donato G., Deloose K., Verbist J., Peeters P., Castriota F. et al. Does free cell area influence the outcome in carotid artery stenting? Eur. J. Vasc. Endovasc. Surg. 2007;33(2):135–141. DOI: 10.1016/j.ejvs.2006.09.019.
17. Hart J.P., Peeters P., Verbist J., Deloose K., Bosiers M. Do device characteristics impact outcome in carotid artery stenting? J. Vasc. Surg. 2006;44(4):725–730. DOI: 10.1016/j.jvs.2006.06.029.
18. De Vries E.E., Meershoek A.J.A., Vonken E.J., den Ruijter H.M., van den Berg J.C., de Borst G.J. et al. A meta-analysis of the effect of stent design on clinical and radiologic outcomes of carotid artery stenting. J. Vasc. Surg. 2019;69(6):1952–1961.e1. DOI: 10.1016/j.jvs.2018.11.017.
19. Tadros R.O., Spyris C.T., Vouyouka A.G., Chung C., Krishnan P., Arnold M.W. et al. Comparing the embolic potential of open and closed cell stents during carotid angioplasty and stenting. J. Vasc. Surg. 2012;56(1):89–95. DOI: 10.1016/j.jvs.2011.12.077.
20. Timaran C.H., Rosero E.B., Higuera A., Ilarraza A., Modrall J.G., Clagett G.P. Randomized clinical trial of open-cell vs closed-cell stents for carotid stenting and effects of stent design on cerebral embolization. J. Vasc. Surg. 2011;54(4):1310–1316.e1. DOI: 10.1016/j.jvs.2011.05.013.
21. Müller M.D., Gregson J., McCabe D.J.H., Nederkoorn P.J., van der Worp H.B., de Borst G.J. et al. Stent Design, Restenosis and Recurrent Stroke After Carotid Artery Stenting in the International Carotid Stenting Study. Stroke. 2019;50(1):3013–3020. DOI: 10.1161/STROKEAHA.118.024076.
22. Jim J., Rubin B.G., Landis G.S., Kenwood C.T., Siami F.S., Sicard G.A. et al. Society for Vascular Surgery Vascular Registry evaluation of stent cell design on carotid artery stenting outcomes. J. Vasc. Surg. 2011;54(1):71–79. DOI: 10.1016/j.jvs.2010.12.054.
23. Grunwald I.Q., Reith W., Karp K., Papanagiotou P., Sievert H., Walter S. et al. Comparison of stent free cell area and cerebral lesions after unprotected carotid artery stent placement. Eur. J. Vasc. Endovasc. Surg. 2012;43(1):10–14. DOI: 10.1016/j.ejvs.2011.10.002.
24. Gray W.A., Chaturvedi S., Verta P., Investigators and the Executive Committees. Thirty-day outcomes for carotid artery stenting in 6320 patients from 2 prospective, multicenter, high- surgical-risk registries. Circ. Cardiovasc. Interv. 2009;2(3):159–166. DOI: 10.1161/CIRCINTERVENTIONS.108.823013.
25. Kouvelos G.N., Patelis N., Antoniou G.A., Lazaris A., Matsagkas M.I. Meta-analysis of the effect of stent design on 30-day outcome after carotid artery stenting. J. Endovasc. Ther. 2015;22(5):789–797. DOI: 10.1177/1526602815598753.
26. Hussain H.G., Aparajita R., Khan S.Z., Rezayat C., McKinsey J.F., Dayal R. Closed-cell stents present with higher velocities on duplex ultrasound compared with open-cell stents after carotid intervention: Short- and mid-term results. Ann. Vasc. Surg. 2011;25(1):55–63. DOI: 10.1016/j.avsg.2010.07.004.
27. Tatli E., Tokatli A., Vatan M.B., Agac M.T., Gunduz H., Akdemir R. et al. Comparison of closed-cell and hybrid-cell stent designs in Carotid artery stenting: Clinical and procedural outcomes. Postepy Kardiol. Interwencyjnej. 2017;13(2):135–141. DOI: 10.5114/pwki.2017.67994.
28. Stabile E., Giugliano G., Cremonesi A., Bosiers M., Reimers B., Setacci C. et al. Impact on outcome of different types of carotid stent: Results from the European Registry of Carotid Artery Stenting. EuroIntervention. 2016;12(2):e265–270. DOI: 10.4244/EIJV12I2A41.
29. Musialek P., Stabile E. Residual plaque prolapse with novel dual-layer carotid stents: is it mesh-covered or not? EuroIntervention. 2017;13(1):1266–1268. DOI: 10.4244/EIJV13I11A199.
30. Wissgott C., Schmidt W., Brandt-Wunderlich C., Behrens P., Andresen R. Clinical results and mechanical properties of the carotid CGUARD double-layered embolic prevention stent. J. Endovasc. Ther. 2017;24(1):130–137. DOI: 10.1177/1526602816671134.
31. Montorsi P., Caputi L., Galli S., Ravagnani P.M., Teruzzi G., Annoni A. et al. Carotid wallstent versus roadsaver stent and distal versus proximal protection on cerebral microembolization during carotid artery stenting. JACC Cardiovasc. Interv. 2020;13(4):403–414. DOI: 10.1016/j.jcin.2019.09.007.
32. Bugurov S.V., Karpenko A.A., Ignatenko P.V., Popova I.V., Starodubtsev V.B., Saaia S.B. et al. Stenting of the carotid artery with CGuard and Acculink stents: Interim results of a randomized trial. Angiology and Vascular Surgery. 2019;25(4):64–69 (In Russ.). DOI: 1033529/ANGIO2019418.
33. Vatan M.B., Acar B.A., Aksoy M., Can Y., Varım C., Agac M.T. et al. Predictors of periprocedural complications of carotid artery stenting – A multivariate analysis of a single-centre experience. Vasa. 2016;45(5):387–393. DOI: 10.1024/0301-1526/a000550.
34. Fanelli F., Boatta E., Cannavale A., Corona M., Lucatelli P., Wlderk A. et al. Carotid artery stenting: Analysis of a 12-year single-center experience. J. Endovasc. Ther. 2012;19(6):749–756. DOI: 10.1583/JEVT-12-3944MR.1
35. Konishi T., Funayama N., Yamamoto T., Hotta D., Nomura R., Nakagaki Y. et al. Stabilization of symptomatic carotid atherosclerotic plaques by statins: a clinico-pathological analysis. Heart Vessels. 2018;33(1):1311–1324. DOI: 10.1007/s00380-018-1193-6.
36. Artom N., Montecucco F., Dallegri F., Pende A. Carotid atherosclerotic plaque stenosis: The stabilizing role of statins. Eur. J. Clin. Invest. 2014;44(11):1122–34. DOI: 10.1111/eci.12340
37. Hopkins L.N., White C.J., Foster M.T., Powell R.J., Zemel G., Diaz-Cartelle J. Carotid artery stenting and patient outcomes: The CABANA surveillance study. Catheter. Cardiovasc. Interv. 2014;84(6):997–1004. DOI: 10.1002/ccd.25578.
38. Matsumura J.S., Gray W., Chaturvedi S., Yamanouchi D., Peng L., Verta P. Results of carotid artery stenting with distal embolic protection with improved systems: Protected Carotid Artery Stenting in Patients at High Risk for Carotid Endarterectomy (PROTECT) trial. J. Vasc. Surg. 2012;55(4):968–976.e5. DOI: 10.1016/j.jvs.2011.10.120.
39. Scheinert D., Reimers B., Cremonesi A., Schmidt A., Sievert H., Rohde S. et al. Independent modular filter for embolic protection in carotid stenting. Circ. Cardiovasc. Interv. 2017;10(3):e004244. DOI: 10.1161/CIRCINTERVENTIONS.116.004244.
40. Macdonald S. Is there any evidence that cerebral protection is beneficial? J. Cardiovasc. Surg. (Torino). 2006;47(2):127–136.
41. Pinter L., Ribo M., Loh C., Lane B., Roberts T., Chou T.M. et al. Safety and feasibility of a novel transcervical access neuroprotection system for carotid artery stenting in the PROOF Study. J. Vasc. Surg. 2011;54(5):1317–1323. DOI: 10.1016/j.jvs.2011.04.040.
42. Verzini F., Cao P., De Rango P., Parlani G., Maselli A., Romano L et al. Appropriateness of learning curve for carotid artery stenting: An analysis of periprocedural complications. J. Vasc. Surg. 2006;44(6):1205–1211. DOI: 10.1016/j.jvs.2006.08.027.
43. Palombo G., Stella N., Fantozzi C., Bozzao A., Taurino M. Transcranial Doppler and diffusion-weighted magnetic resonance evaluation of cerebral embolization occurring during transfemoral carotid stenting with proximal flow blockage. J. Cardiovasc. Surg. (Torino). 2016;57(1): 52–57.
44. Bijuklic K., Wandler A., Hazizi F., Schofer J. The PROFI study (Prevention of cerebral embolization by proximal balloon occlusion compared to filter protection during carotid artery stenting): A prospective randomized trial. J. Am. Coll. Cardiol. 2012;59(15):1383–1389. DOI: 10.1016/j.jacc.2011.11.035.
45. Angelini A., Reimers B., Barbera M.D., Saccà S., Pasquetto G., Cernetti C. et al. Cerebral protection during carotid artery stenting: Collection and histopathologic analysis of embolized debris. Stroke. 2002;33(2):456–461. DOI: 10.1161/hs0202.102337.
46. Müller M.D., Ahlhelm F.J., Von Hessling A., Doig D., Nederkoorn P.J., MacDonald S. et al. Vascular anatomy predicts the risk of cerebral ischemia in patients randomized to carotid stenting versus endarterectomy. Stroke. 2017;48(5):1285–1292. DOI: 10.1161/STROKEAHA.116.014612.
47. Ikeda G., Tsuruta W., Nakai Y., Shiigai M., Marushima A., Masumoto T. et al. Anatomical risk factors for ischemic lesions associated with carotid artery stenting. Interv. Neuroradiol. 2014;20(6):746–754. DOI: 10.15274/INR-2014-10075.
48. Liang P., Wu W.W., Schermerhorn M.L. Recent advances in the treatment of carotid artery disease. J. Cardiovasc. Surg. 2019;60(3):345–353. DOI: 10.23736/s0021-9509.19.10922-6.
49. Kumins N.H., King A.H., Ambani R.N., Thomas J.P., Kim A.H., Augustin G. et al. Anatomic criteria in the selection of treatment modality for atherosclerotic carotid artery disease. J. Vasc. Surg. 2020;72(4):1395–1404. DOI: 10.1016/j.jvs.2020.01.041.
50. Kwolek C.J., Jaff M.R., Leal J.I., Hopkins L.N., Shah R.M., Hanover T.M. et al. Results of the ROADSTER multicenter trial of transcarotid stenting with dynamic flow reversal. J. Vasc. Surg. 2015;62(5):1227–1234.e1. DOI: 10.1016/j.jvs.2015.04.460.
51. Brott T.G., Hobson R.W., Howard G., Roubin G.S., Clark W.M., Brooks W. et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N. Engl. J. Med. 2010;363(1):11–23. DOI: 10.1056/NEJMoa0912321.
52. Schermerhorn M.L., Liang P., Dakour-Aridi H., Kashyap V.S., Wang G.J., Nolan B.W. et al. In-hospital outcomes of transcarotid artery revascularization and carotid endarterectomy in the Society for Vascular Surgery Vascular Quality Initiative. J. Vasc. Surg. 2020;71(1):87–95. DOI: 10.1016/j.jvs.2018.11.029.
53. Kashyap V.S., King A.H., Foteh M.I., Janko M., Jim J., Motaganahalli R.L. et al. A multi-institutional analysis of transcarotid artery revascularization compared to carotid endarterectomy. J. Vasc. Surg. 2019;70(1):123–129. DOI: 10.1016/j.jvs.2018.09.060.
54. Schermerhorn M.L., Liang P., Eldrup-Jorgensen J., Cronenwett J.L., Nolan B.W., Kashyap V.S. et al. Association of transcarotid artery revascularization vs transfemoral carotid artery stenting with stroke or death among patients with carotid artery stenosis. JAMA. 2019;322(23):2313–2322. DOI: 10.1001/jama.2019.18441.
55. Sfyroeras G.S., Moulakakis K.G., Markatis F., Antonopoulos C.N., Antoniou G.A., Kakisis J.D. et al. Results of carotid artery stenting with transcervical access. J. Vasc. Surg. 2013;58(5):1402– 1407. DOI: 10.1016/j.jvs.2013.07.111.
56. Pipinos I.I., Johanning J.M., Pham C.N., Soundararajan K., Lynch T.G. Transcervical approach with protective flow reversal for carotid angioplasty and stenting. J. Endovasc. Ther. 2005;12(4):446–453. DOI: 10.1583/05-1561.1.
57. Heyer E.J., Gold M.I., Kirby E.W., Zurica J., Mitchell E., Halazun H.J. et al. A study of cognitive dysfunction in patients having carotid endarterectomy performed with regional anesthesia. Anesth. Analg. 2008;107(2):636–642. DOI: 10.1213/ane.0b013e3181770d84.
Review
For citations:
Osipova O.S., Popova I.V., Starodubtsev V.B., Bugurov S.V., Cheban A.V., Karpenko A.A. Outcomes of using various designs of carotid stents. Siberian Journal of Clinical and Experimental Medicine. 2021;36(1):30-37. (In Russ.) https://doi.org/10.29001/2073-8552-2021-36-1-30-37
Views:
780
.png)
Email this article 